The Biotech Startups Podcast 🧬 Multi-Edit CAR T-Cells: The Crazy Science That Might Cure Brain Cancer | Aaron Edwards (Part 4/4)
31 snips
Jul 30, 2025 Aaron Edwards, co-founder of KiraGen Bio, shares his journey from a Harvard Business School project to pioneering a multi-edit CAR T-cell therapy for solid tumors. He discusses tackling immune suppression in glioblastoma, leveraging machine learning, and the challenges of fundraising. Edwards emphasizes the importance of discipline, innovative design strategies, and authentic leadership in the biotech space. His insights offer a fresh perspective on overcoming the complexities of brain cancer treatment while navigating the startup landscape.
AI Snips
Chapters
Transcript
Episode notes
Focus On Milestones, Not Science For Science
- Run lean and focus on milestones that directly advance your goal of clinical progress.
- Avoid scientific distractions that don’t move the company towards patient impact quickly.
Early Company Building Experience
- Early company building involved limited funding, setting up a minimal lab in a shared academic space, and opportunistic hiring.
- Team members who trusted each other from past collaborations enabled efficient lab and business operations.
ML Rationalizes Complex Edits
- Machine learning is used not just for screening but to rationalize design decisions and reduce costly wet lab permutations.
- This technology could eventually enable democratized partnerships and service platforms in cell therapy development.